Jane J. Zara

Array ( [id] => 5807707 [patent_doc_number] => 20060094061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 11/251465 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31057 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094061.pdf [firstpage_image] =>[orig_patent_app_number] => 11251465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648929 [patent_doc_number] => 20060134661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Treatment of cancer and compositions' [patent_app_type] => utility [patent_app_number] => 11/249589 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13455 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134661.pdf [firstpage_image] =>[orig_patent_app_number] => 11249589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5326387 [patent_doc_number] => 20090064377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'METHOD AND MEANS FOR TARGETED NUCLEOTIDE EXCHANGE' [patent_app_type] => utility [patent_app_number] => 12/088813 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10782 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20090064377.pdf [firstpage_image] =>[orig_patent_app_number] => 12088813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814072 [patent_doc_number] => 20060084152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Corynebacterium glutamicum genes encoding metabolic pathway proteins' [patent_app_type] => utility [patent_app_number] => 11/239674 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57085 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084152.pdf [firstpage_image] =>[orig_patent_app_number] => 11239674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821061 [patent_doc_number] => 20060025374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Novel oligoribonucleotide derivatives for specific inhibition of gene expression' [patent_app_type] => utility [patent_app_number] => 11/233907 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8144 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025374.pdf [firstpage_image] =>[orig_patent_app_number] => 11233907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4500739 [patent_doc_number] => 07919472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Enhanced antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/231243 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19048 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919472.pdf [firstpage_image] =>[orig_patent_app_number] => 11231243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738450 [patent_doc_number] => 20060008841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Aptamer capable of specifically adsorbing to verotoxin-1 and method for obtaining the aptamer' [patent_app_type] => utility [patent_app_number] => 11/224268 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4677 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008841.pdf [firstpage_image] =>[orig_patent_app_number] => 11224268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678346 [patent_doc_number] => 20060183702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics' [patent_app_type] => utility [patent_app_number] => 11/222346 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 50874 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183702.pdf [firstpage_image] =>[orig_patent_app_number] => 11222346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648927 [patent_doc_number] => 20060134659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Method for demethylating target methylated region of genome DNA' [patent_app_type] => utility [patent_app_number] => 11/221012 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5037 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134659.pdf [firstpage_image] =>[orig_patent_app_number] => 11221012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210007 [patent_doc_number] => 20070248591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Preventive/Therapeutic Drug for Arteriosclerosis' [patent_app_type] => utility [patent_app_number] => 11/662079 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36782 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248591.pdf [firstpage_image] =>[orig_patent_app_number] => 11662079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620023 [patent_doc_number] => 20060189557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Regulation of oncogenes by microRNAs' [patent_app_type] => utility [patent_app_number] => 11/219379 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 23056 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189557.pdf [firstpage_image] =>[orig_patent_app_number] => 11219379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828126 [patent_doc_number] => 20060063230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Sulfatases and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/219360 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 46149 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063230.pdf [firstpage_image] =>[orig_patent_app_number] => 11219360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648926 [patent_doc_number] => 20060134658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Use of RNA trans-splicing for generation of interfering RNA molecules' [patent_app_type] => utility [patent_app_number] => 11/199917 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8237 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134658.pdf [firstpage_image] =>[orig_patent_app_number] => 11199917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821059 [patent_doc_number] => 20060025372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Antisense modulation of PTP1B expression' [patent_app_type] => utility [patent_app_number] => 11/194776 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34076 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025372.pdf [firstpage_image] =>[orig_patent_app_number] => 11194776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827865 [patent_doc_number] => 20060063177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Biomarkers and assays for carcinogenesis' [patent_app_type] => utility [patent_app_number] => 11/189064 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10035 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063177.pdf [firstpage_image] =>[orig_patent_app_number] => 11189064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242867 [patent_doc_number] => 20070021362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Antisense antibacterial method and compound' [patent_app_type] => utility [patent_app_number] => 11/173847 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17765 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021362.pdf [firstpage_image] =>[orig_patent_app_number] => 11173847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085870 [patent_doc_number] => 20070275921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Oligomeric Compounds That Facilitate Risc Loading' [patent_app_type] => utility [patent_app_number] => 11/569929 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44771 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275921.pdf [firstpage_image] =>[orig_patent_app_number] => 11569929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895418 [patent_doc_number] => 20060003957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'RNA virus expression and replication, methods and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/122944 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 27385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003957.pdf [firstpage_image] =>[orig_patent_app_number] => 11122944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591429 [patent_doc_number] => 20060040881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Modulators of coagulation factors' [patent_app_type] => utility [patent_app_number] => 11/113378 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23172 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040881.pdf [firstpage_image] =>[orig_patent_app_number] => 11113378 [rel_patent_id] =>[rel_patent_doc_number] =>)